For example, anti-TNF therapies are effective in RA, colitis and Crohn’s disease, psoriasis and ankylosing spondylitis, or anti-IL-1 antibodies, effective in RA or autoinflammatory disorders. This evidence concerns the gene IL1B and rheumatoid arthritis.